Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Enrique Fuentes-Mattei
Combining Anti-Mir-155 With Chemotherapy for the Treatment of Lung Cancers
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Nanoparticles for the Treatment of Lung Cancers
Journal of Young Pharmacists
Toxicology
Pharmaceutics
Pharmacology
Patients’ Retrospective Assessment of Palliative Chemotherapy for Lung or Gastrointestinal Cancers
Journal of Community and Supportive Oncology
Oncology
Hematology
Potential Diagnostic Value of miR-155 in Serum From Lung Adenocarcinoma Patients
Oncology Reports
Medicine
Cancer Research
Oncology
The Diagnosis and Treatment for Multiple Primary Lung Cancers.
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
High Expression of miR-155 and miR-21 in the Recurrence or Metastasis of Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Predictive Relevance of miR‑34a, miR‑224 and miR‑342 in Patients With Advanced Squamous Cell Carcinoma of the Lung Undergoing Palliative Chemotherapy
Oncology Letters
Cancer Research
Oncology
Serum Levels of miR-29, miR-122, miR-155 and miR-192 Are Elevated in Patients With Cholangiocarcinoma
PLoS ONE
Multidisciplinary
Lactosylated Gramicidin-Based Lipid Nanoparticles (Lac-Gln) for Targeted Delivery of Anti-miR-155 to Hepatocellular Carcinoma
Journal of Controlled Release
Pharmaceutical Science
miR-155 Meets the JAK/STAT Pathway
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology